21 March 2025 Ahead of the long-awaited Industrial Strategy for life sciences, RSM UK calls on the government to  address challenges around capital, talent and access to markets if the UK’s life sciences sector is to become an industry leader on the global stage. The UK’s life sciences sector comprises over 6,800 businesses, generating more than £100bn in turnover in 2021/22. The sector relies heavily on the UK’s research and development (R&D) scheme as a form of funding, with the pharmaceutical industry accounting for 18% of all UK R&D in 2022 – the highest of any…

On Friday 14 March, as part of a two-day visit to the East of England organised by Andrew Wood, Hon Dutch Consul for East Anglia with support from Norfolk County Council’s Inward Investment Team, Dutch Ambassador to the UK, Paul Huijts, visited scientists at some of the world-leading research institutes at Norwich Research Park. After a networking lunch at which Nick Talbot, Executive Director and Group Leader of The Sainsbury Laboratory, provided the Ambassador with an overview of the park campus, Mr Huijts met with scientists at the leading edge of research into the role of the gut…

Oversubscribed financing led by Cambridge Innovation Capital and SV Health Investors’ Dementia Discovery Fund with M Ventures and Pfizer Ventures joining Investment will support further development of CNS penetrant therapeutics based on the Company’s TRIMTACTM aggregate-selective degraders Cambridge, UK, 05 March 2025: TRIMTECH Therapeutics, a biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, today announced the closing of its $31 million (£25 million) seed funding round. The financing was led by Cambridge Innovation Capital (CIC…

• CDMO specialist signs long-term lease at Unity Campus• Unity Campus nears full occupancy with latest signing  Cambridge, 13th March 2025: Leading regional property investor and developer Howard Group, is delighted to announce a major new signing at its flagship science and technology hub Unity Campus. Further strengthening South Cambridge’s growing bioscience cluster, Advent Bioservices has committed to a 5+5-year lease of lab and office space within the Cadence building, joining an impressive roster of life science innovators at the campus.The addition of Advent Bioservices means that…

London BioScience Innovation Centre welcomes Laverock Therapeutics to its newly completed fully fitted lab space within the Apex Building, Tribeca London- Laverock Therapeutics re-locates to LBIC to facilitate future growth, representing a key milestone for the company as it reports significant progress with its platform technologies, product pipeline and commercial offerings- Fit-out complete, Laverock Therapeutics is the first company to take up occupation within LBIC’s new grow-on lab space at Tribeca LondonLONDON, UK-  17th March 2025: London BioScience Innovation Centre (LBIC) is…

AMSBIO has launched GMP grade StemFit® for Differentiation - a chemically defined and animal component-free formulation that enables unmatched differentiation of human Induced Pluripotent Stem (hiPS) and Embryonic Stem (hES) cells. This medium now complies with Good Manufacturing Practices, as required for downstream clinical applications. The unique chemically defined composition of StemFit® for Differentiation minimizes lot-to-lot variation, enabling highly consistent cell differentiation. The animal-origin free composition minimizes the risk of immunogenic contamination.…

    3 July | Babraham Research Campus Introducing ON Helix 2025ON Helix brings together key players in life sciences to explore critical themes shaping the journey from science to better patient outcomes. Through high quality presentations and panel discussions, ON Helix 2025 will discover and discuss the following themes:•    Harnessing the Body’s Defences•    Adoption of AI in Innovative Drug Discovery •    Getting Ready for Clinic: Transformative Technologies•    Invention,…

London, March 13, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for ExpressionEdits and is pleased to announce the placement of Dr. Amrik Basran as Chief Scientific Officer (CSO).ExpressionEdits is a biotechnology company leveraging AI-driven insights and proprietary intronization technology to enhance protein expression.Dr. Basran is a seasoned drug discovery leader with over 20 years of experience, specializing in biologic therapies and antibody mimetics…

Prof Jonathan Jones, of The Sainsbury Laboratory at Norwich Research Park, has been selected as a 2025 Wolf Prize Laureate in Agriculture along with Professors Jeffery L. Dangl and Brian J. Staskawicz "for groundbreaking discoveries of the immune system and disease resistance in plants." The Wolf Prize is awarded annually to exceptional individuals across scientific and artistic disciplines. In science, the prize is awarded in Medicine, Agriculture, Mathematics, Chemistry, and Physics. Now in its 46th year, the Wolf Prize has recognized 382 scientists and artists worldwide for their…

Arecor Therapeutics plc (“Arecor” or the “Company”) ARECOR ESTABLISHES PARTNERSHIP WITH BIOPHARMACEUTICAL COMPANY TO DEVELOP NOVEL FORMULATION OF PEPTIDE THERAPY - Partner to fund development work with option to acquire rights to proprietary formulation under Arecor’s technology licensing model Cambridge, UK, 12 March 2025: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces a formulation development collaboration with a clinical-stage biopharmaceutical company developing peptide therapies. The partnership…